Compare EVO & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | EQBK |
|---|---|---|
| Founded | 1993 | 2002 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 994.5M | 989.1M |
| IPO Year | N/A | 2015 |
| Metric | EVO | EQBK |
|---|---|---|
| Price | $2.72 | $48.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $51.33 |
| AVG Volume (30 Days) | 28.7K | ★ 65.9K |
| Earning Date | 04-08-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 1.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | N/A |
| Revenue This Year | $1.37 | $74.58 |
| Revenue Next Year | $10.05 | $5.11 |
| P/E Ratio | ★ N/A | $59.93 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.31 | $36.04 |
| 52 Week High | $4.42 | $50.07 |
| Indicator | EVO | EQBK |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 69.94 |
| Support Level | $2.63 | $44.45 |
| Resistance Level | $3.82 | $48.40 |
| Average True Range (ATR) | 0.07 | 0.85 |
| MACD | -0.03 | 0.26 |
| Stochastic Oscillator | 27.55 | 96.67 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.